Stryker sell the Hi-Rise unit for $410,000 in the US Market and CVB sells to Stryker for $360,000 in which CVB makes 50% Gross Profit - with recurring revenue of $25000-$30'000 in service charges.This technology is first to market opportunity with a targeted 10 Billion US Market and 2.7 Billion - (SAAS) CVB AI Platform .
With the implications of the stream line created by in-house bone density tests ( one patient visit) this is compelling IMHO from my medical background with Doctors re- enbursments $240 Cat Scan - $140 Bone Density Test.
Harvard,Penn,UCLA,HSS are hospitals already using the Hi-Rise with Stryker moving on the group surgeon medical centre which will follow the the US Hospitals success.
The FDA approval this week for the full - body scan is very exciting and it's potential IMHO
- Forums
- ASX - By Stock
- CVB
- Ann: Sales Update for Q4 FY2024
Ann: Sales Update for Q4 FY2024, page-23
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVB (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $53.32M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.5¢ | $50.21K | 280.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6428 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2992 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6428 | 0.175 |
4 | 39249 | 0.170 |
3 | 69021 | 0.165 |
3 | 44000 | 0.160 |
4 | 34333 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 2992 | 2 |
0.200 | 92398 | 2 |
0.205 | 37863 | 1 |
0.210 | 45000 | 1 |
0.215 | 9953 | 1 |
Last trade - 14.10pm 28/08/2024 (20 minute delay) ? |
Featured News
CVB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online